Dr Reddys Laboratories (RDY) Invested Capital (2012 - 2026)

Dr Reddys Laboratories' Invested Capital history runs 14 years deep, the most recent figure standing at $5.9 billion for Q1 2026.

• In Q1 2026, Invested Capital rose 50.11% year-over-year to $5.9 billion; the TTM figure through Mar 2026 stood at $5.9 billion (up 50.11% YoY), while the FY2026 annual figure was $5.8 billion, up 46.01% from the prior year.
• Invested Capital was $5.9 billion for Q1 2026 at Dr Reddys Laboratories, up from $4.0 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $5.9 billion in Q1 2026 to a low of $185.0 million in Q3 2023.
• Historically, Invested Capital has averaged $3.4 billion across 5 years, with a median of $3.8 billion in 2023.
• The sharpest annual moves came in 2022 and 2025: Invested Capital surged 2570.79% in 2022, then fell 9.5% in 2025.
• A 5-year view of Invested Capital shows it stood at $2.6 billion in 2022, then slumped by 92.95% to $185.0 million in 2023, then jumped by 2259.25% to $4.4 billion in 2024, then dropped by 9.5% to $4.0 billion in 2025, then jumped by 50.11% to $5.9 billion in 2026.
• The last three Invested Capital figures came in at $5.9 billion (Q1 2026), $4.0 billion (Q1 2025), and $4.4 billion (Q1 2024), per Business Quant data.